Back
Day Range
$23.06
$24.67
52-Week Range
$12.72
$29.25
Volume
1,606,115
50D / 200D Avg
$26.10
/
$20.79
Prev Close
$22.98
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -12.0 | 0.4 |
| P/B | 7.0 | 2.9 |
| ROE % | -62.5 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$35.67
+46.3%
Low: $16.00
High: $50.00
Forward EPS
-$2.63
Est. Revenue
10 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$2.09
$2.09 – $2.09
|
1.3 B | 11 |
| FY2029 |
-$1.37
-$1.37 – -$1.37
|
460 M | 8 |
| FY2028 |
-$2.46
-$3.81 – -$1.47
|
110 M | 13 |
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -376.63M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-62.46%
ROIC-46.44%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio11.16
Interest Coverage0.00
Valuation
P/E Ratio
-11.99
P/B Ratio7.01
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -413.84M |
| ROE | -62.46% | ROA | -53.31% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -376.63M |
| ROIC | -46.44% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 11.16 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -11.99 | P/B Ratio | 7.01 |
| P/S Ratio | N/A | PEG Ratio | -0.14 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 4.96B | Enterprise Value | 4.25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -413.84M | -259.34M | -210.96M | -156.73M | -107.43M |
| EPS (Diluted) | -2.73 | -1.88 | -1.71 | -1.43 | -1.22 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -438.15M | -270.21M | -208.28M | -156.03M | -108.12M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 776.22M | 666.71M | 405.84M | 515.56M | 412.49M |
| Total Liabilities | 68.78M | 48.96M | 43.34M | 45.74M | 21.01M |
| Shareholders' Equity | 707.45M | 617.76M | 362.49M | 469.83M | 391.48M |
| Total Debt | 98,000.0 | 138,000.0 | 1.22M | 2.36M | 3.42M |
| Cash & Equivalents | 713.97M | 635.37M | 376.53M | 493.82M | 400.15M |
| Current Assets | 767.66M | 665.77M | 404.33M | 512.93M | 409.01M |
| Current Liabilities | 68.78M | 48.61M | 43.30M | 44.52M | 18.77M |